If you are physically able, try your best to make at least fifteen minutes of exercise part of your routine.
Chicago Bears quarterback Jay Cutler visited the University of Chicago’s Kovler Diabetes Center on World Diabetes Day.
Cutler met with teenage diabetics to discuss his experience with diabetes. The quarterback recently recorded six videos that detail his experience with diabetes, its impact on his life and sports career, and how he manages the disease as a professional athlete...
Spherix Inc., an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, and biotechnology companies, announced positive interim Phase 3 clinical results for the use of D-tagatose for treatment of type 2 diabetes patients...
November 14 is World Diabetes Day. On that day, at 14:00 hours (local time), thousands of people with diabetes will test their blood sugar, do 14 minutes of exercise, test again and share their results on TuDiabetes or on Twitter.
The event is called The Big Blue Test because blue is the color associated with World Diabetes Day.
Now science may have found a way of mobilizing stem cells within the body to treat this health issue, which affects more than three million Americans annually.
Recent studies have shown that surgically moving mesenchymal stem cells (MSCs)...
Researchers at the Hebrew University in Jerusalem, in collaboration with Japanese and American researchers, have discovered a mechanism of insulin production within the pancreas.
The team, led by Prof. Yuval Dor, explored the role of LKB1, a gene involved in many cellular functions, whose role in the pancreas had not been examined before.
Novo Nordisk's CEO, Lars Sorensen, told Reuters at the Reuters Health Summit in New York that the new diabetes drug Victoza has reached the final decision stage at the U.S. FDA. Sorensen expects the drug will be approved, although "potentially all the outcomes are still possible...
Lars Sorensen, Novo's chief executive, speaking at the Reuters Health Summit, said the company could introduce a oral insulin tablet to the market within six years.
A number of companies have already tried to develop inhaled insulin, including Pfizer Inc, whose product Exubera, was discontinued in 2007. This form of insulin has raised concerns that it could cause lung damage.
Excitement is building for the upcoming World Diabetes Day on November 14. The International Diabetes Federation reports more than 660 monuments- including the Empire State Building, London Eye, Christ the Redeemer, Burj al Arab and the Obelisque in Paris –will light up in blue this Saturday.
Compugen Ltd. announced today the discovery and experimental confirmation of a genetic marker for type 2 diabetes. A predisposition marker is of particular value in type 2 diabetes since lifestyle plays an important role in the disease. Following diagnosis, those at high-risk might benefit from more aggressive management either through changes in lifestyle or drug treatment.